The Lysosomal Disease Summit brings together researchers, clinicians, industry experts, and advocacy leaders from across the Asia-Pacific region and beyond to advance understanding, diagnosis, and treatment of lysosomal storage disorders.
Now in its third year, this collaborative platform offers:
Whether you’re a researcher, clinician, advocate, or industry professional working in the lysosomal disease space, this summit provides an excellent opportunity to connect, learn, and contribute to advancing care for these rare conditions.
The Lysosomal Disease Summit is independently managed by Etherio, in collaboration with Fabry Australia.